Demographics, Investigations, Treatment at First Disease Event, Overall Disease Course, and Outcome in the Total Pediatric Cohort of Patients With MOGAD (A), in Children With Monophasic vs Relapsing Disease (B), and in Patients With EDSS 0 vs EDSS > 0 at Last Follow-up (C) (Univariate Analysis)